摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trifluoro-N-(2-phenylacetyl)methanesulfonamide | 174282-49-6

中文名称
——
中文别名
——
英文名称
trifluoro-N-(2-phenylacetyl)methanesulfonamide
英文别名
trifluoro-N-(phenylacetyl)methanesulfonamide;2-phenyl-N-(trifluoromethylsulfonyl)acetamide
trifluoro-N-(2-phenylacetyl)methanesulfonamide化学式
CAS
174282-49-6
化学式
C9H8F3NO3S
mdl
——
分子量
267.229
InChiKey
ILFOIDHBFPFZMF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    71.6
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    trifluoro-N-(2-phenylacetyl)methanesulfonamide苯肼二氯甲烷 为溶剂, 以0.20 g的产率得到苯乙酸苯酰肼
    参考文献:
    名称:
    Reactions of N-sulfinyltrifluoromethanesulfonamide with carboxylic acids
    摘要:
    Phenylacetic, diphenylacetic, salicylic, and cinnamic acids reacted with N-sulfinyltrifluoromethanesulfonamide (CF3SO2NSO) to give the corresponding N-acyltrifluoromethanesulfonamides CF3SO2NHCOR (R = PhCH2, Ph2CH, o-HOC6H4, PhCH=CH). The reaction of N-sulfinyl-trifluoromethanesulfonamide with 3-hydrazinobenzoic acid Occurred at the hydrazino group of the latter with conservation of the carboxy group and without elimination of SO2, and the product was 3-(2-sulfinylhydrazino)benzoic acid OSNNHC6H4CO2H.
    DOI:
    10.1134/s1070428008080022
  • 作为产物:
    描述:
    苯乙酸 、 alkaline earth salt of/the/ methylsulfuric acid 在 氯化亚砜三乙胺 作用下, 以 丙酮 为溶剂, 反应 1.25h, 生成 trifluoro-N-(2-phenylacetyl)methanesulfonamide
    参考文献:
    名称:
    Synthesis and Evaluation of N-(Phenylacetyl)trifluoromethanesulfonamides as Anticonvulsant Agents
    摘要:
    A series of N-(phenylacetyl)trifluoromethanesulfonamides (3a-g) was prepared according to the Topliss scheme in order to determine if aryl substitutents would influence anticonvulsant activity. In initial (phase I) screening and quantitative (phase II) evaluation, all seven compounds exhibited significant activity against MES- and scMet-induced seizures. N-(Phenylacetyl)trifluoromethanesulfonamide (3a) was then advanced through five additional testing phases (phases III-VII). Compound 3a displayed good oral bioavailability, low toxicity, and a larger protective index in mice than the prototype drugs, phenytoin, phenobarbital, valproate, and ethosuximide. Additionally, 3a exhibited a longer time to peak effect in all tests and a greater 24-h margin of safety (HD50/ED(50)) than the prototypes. Compound 3a blocked picrotoxin-induced seizures but was ineffective. against seizures induced by bicuculline or strychnine. In vitro receptor binding studies revealed that 3a did not displace [H-3]-labeled gamma-aminobutyric acid or [H-3]-labeled flunitrazepam, and tolerance did not develop during 5-day chronic administration.
    DOI:
    10.1021/jm950761q
点击查看最新优质反应信息

文献信息

  • Gmelin Handbuch der Anorganischen Chemie, Gmelin Handbook: F: PerFHalOrg.2, 1.3.3, page 120 - 137
    作者:
    DOI:——
    日期:——
  • US3637845
    申请人:——
    公开号:——
    公开(公告)日:——
  • Synthesis and Evaluation of <i>N</i>-(Phenylacetyl)trifluoromethanesulfonamides as Anticonvulsant Agents
    作者:Patrick T. Flaherty、Thomas D. Greenwood、Amy L. Manheim、James F. Wolfe
    DOI:10.1021/jm950761q
    日期:1996.1.1
    A series of N-(phenylacetyl)trifluoromethanesulfonamides (3a-g) was prepared according to the Topliss scheme in order to determine if aryl substitutents would influence anticonvulsant activity. In initial (phase I) screening and quantitative (phase II) evaluation, all seven compounds exhibited significant activity against MES- and scMet-induced seizures. N-(Phenylacetyl)trifluoromethanesulfonamide (3a) was then advanced through five additional testing phases (phases III-VII). Compound 3a displayed good oral bioavailability, low toxicity, and a larger protective index in mice than the prototype drugs, phenytoin, phenobarbital, valproate, and ethosuximide. Additionally, 3a exhibited a longer time to peak effect in all tests and a greater 24-h margin of safety (HD50/ED(50)) than the prototypes. Compound 3a blocked picrotoxin-induced seizures but was ineffective. against seizures induced by bicuculline or strychnine. In vitro receptor binding studies revealed that 3a did not displace [H-3]-labeled gamma-aminobutyric acid or [H-3]-labeled flunitrazepam, and tolerance did not develop during 5-day chronic administration.
  • Reactions of N-sulfinyltrifluoromethanesulfonamide with carboxylic acids
    作者:B. A. Shainyan、L. L. Tolstikova、A. V. Bel’skikh
    DOI:10.1134/s1070428008080022
    日期:2008.8
    Phenylacetic, diphenylacetic, salicylic, and cinnamic acids reacted with N-sulfinyltrifluoromethanesulfonamide (CF3SO2NSO) to give the corresponding N-acyltrifluoromethanesulfonamides CF3SO2NHCOR (R = PhCH2, Ph2CH, o-HOC6H4, PhCH=CH). The reaction of N-sulfinyl-trifluoromethanesulfonamide with 3-hydrazinobenzoic acid Occurred at the hydrazino group of the latter with conservation of the carboxy group and without elimination of SO2, and the product was 3-(2-sulfinylhydrazino)benzoic acid OSNNHC6H4CO2H.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐